This week on "Sunday Morning" (November 28)
CBSN
Host: Jane Pauley
COVER STORY: Hopes and fears over a new Alzheimer's drugThe FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer's patients, including a former neurologist who enrolled in an early trial of Aduhelm.
BOOK EXCERPT: "A Tattoo On My Brain: A Neurologist's Personal Battle Against Alzheimer's Disease"Dr. Daniel Gibbs writes about how, after spending his career caring for patients with Alzheimer's, he has now moved to studying the disease from the perspective of a patient himself.
